Zobrazeno 1 - 10
of 65
pro vyhledávání: '"AJ Hatswell"'
Publikováno v:
Value in Health. 25:S318-S319
Publikováno v:
Value in Health. 21:S111-S112
Autor:
AJ Hatswell
Publikováno v:
Value in Health. 21:S101
Publikováno v:
Value in Health. 20:A449
Publikováno v:
Value in Health. 19:A348
Autor:
Latimer NR; Delta Hat Limited, Bramley House, Bramley Road, Nottingham, NG10 3SX, UK. nlatimer@deltahat.com.; University of Sheffield, Sheffield, UK. nlatimer@deltahat.com., Taylor K; Delta Hat Limited, Bramley House, Bramley Road, Nottingham, NG10 3SX, UK., Hatswell AJ; Delta Hat Limited, Bramley House, Bramley Road, Nottingham, NG10 3SX, UK.; Department of Statistical Science, University College London, London, UK., Ho S; Bristol Myers Squibb, Uxbridge, London, UK., Okorogheye G; Bristol Myers Squibb, Uxbridge, London, UK., Chen C; Bristol Myers Squibb, Lawrenceville, NJ, USA., Kim I; Bristol Myers Squibb, Lawrenceville, NJ, USA., Borrill J; Bristol Myers Squibb, Uxbridge, London, UK., Bertwistle D; Bristol Myers Squibb, Uxbridge, London, UK.
Publikováno v:
PharmacoEconomics [Pharmacoeconomics] 2024 Dec; Vol. 42 (12), pp. 1395-1412. Date of Electronic Publication: 2024 Sep 20.
Autor:
Taylor K; Delta Hat Limited, Nottingham, UK. ktaylor@deltahat.com., Latimer NR; Delta Hat Limited, Nottingham, UK.; Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK., Douglas T; Delta Hat Limited, Nottingham, UK., Hatswell AJ; Delta Hat Limited, Nottingham, UK.; Department of Statistical Science, University College London, London, UK., Ho S; Bristol Myers Squibb, Uxbridge, London, UK., Okorogheye G; Bristol Myers Squibb, Uxbridge, London, UK., Borril J; Bristol Myers Squibb, Uxbridge, London, UK., Chen C; Bristol Myers Squibb, Lawrenceville, NJ, USA., Kim I; Bristol Myers Squibb, Lawrenceville, NJ, USA., Bertwistle D; Bristol Myers Squibb, Uxbridge, London, UK.
Publikováno v:
PharmacoEconomics [Pharmacoeconomics] 2024 Nov; Vol. 42 (11), pp. 1181-1196. Date of Electronic Publication: 2024 Aug 23.
Autor:
Briggs AH; London School of Hygiene and Tropical Medicine, London, UK; Avalon Health Economics, Morristown, NJ, USA. Electronic address: andrew.briggs@lshtm.ac.uk., Doyle-Connolly A; Avalon Health Economics, Morristown, NJ, USA., Schneider J; Avalon Health Economics, Morristown, NJ, USA., Podkonjak T; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Taylor H; Takeda UK Ltd, London, UK., Roffe E; Takeda UK Ltd, London, UK., Low E; Eric Low Consulting, Edinburgh, UK., Davis S; University of Sheffield, Sheffield, UK., Kaiser M; Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK., Hatswell AJ; Delta Hat, Nottingham, UK., Rabin N; University College Hospital, London, UK.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Oct 29. Date of Electronic Publication: 2024 Oct 29.
Autor:
Oldenburg J; Institute of Experimental Haematology and Transfusion Medicine and Center for Rare Diseases, University Hospital Bonn, Bonn, Germany. johannes.oldenburg@ukbonn.de., Chambost H; Department of Pediatric Hematology Oncology, AP-HM, Children Hospital La Timone & Aix Marseille University, INSERM, INRA, C2VN, Marseille, France., Liu H; BioMarin Pharmaceutical Inc., Novato, CA, USA., Hawes C; BioMarin UK Ltd, London, UK., You X; BioMarin Pharmaceutical Inc., Novato, CA, USA., Yang X; BioMarin Pharmaceutical Inc., Novato, CA, USA., Newman V; BioMarin UK Ltd, London, UK., Robinson TM; BioMarin Pharmaceutical Inc., Novato, CA, USA., Hatswell AJ; DeltaHat Limited, Nottingham, UK.; Department of Statistical Science, University College London, London, UK., Hinds D; BioMarin Pharmaceutical Inc., Novato, CA, USA., Santos S; BioMarin UK Ltd, London, UK., Ozelo M; Hemocentro UNICAMP, Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
Publikováno v:
Advances in therapy [Adv Ther] 2024 Jun; Vol. 41 (6), pp. 2267-2281. Date of Electronic Publication: 2024 Apr 15.
Autor:
Batteson R; Delta Hat Ltd, Nottingham, UK. rbatteson@deltahat.com., Hook E; Delta Hat Ltd, Nottingham, UK., Wheat H; Delta Hat Ltd, Nottingham, UK., Hatswell AJ; Delta Hat Ltd, Nottingham, UK.; Department of Statistical Science, UCL, London, UK., Vioix H; Global Evidence and Value Department, Merck Healthcare KGaA, Darmstadt, Germany., McLean T; Merck Serono Ltd., an affiliate of Merck KGaA, Feltham, UK., Alexopoulos ST; Merck Serono Ltd., an affiliate of Merck KGaA, Feltham, UK., Baijal S; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Paik PK; Weill Cornell Medical College, New York, NY, USA.; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Targeted oncology [Target Oncol] 2024 Mar; Vol. 19 (2), pp. 191-201. Date of Electronic Publication: 2024 Mar 16.